Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Vitara RX vs Alegro Health

Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, Alegro Health a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Vitara RX

#4 · Grade A · Best Value

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full Vitara RX review →
VS

Alegro Health

#270 · Grade C · Watch List

Est. first month

From $199/mo (starting dose, compounded)

Save ~85% vs brand-name
Get this deal Full Alegro Health review →

The verdict

Better value: Vitara RX

Vitara RX takes it on Value Score, 91 to 68 an est. $99/mo first month, with no teaser step-up baked in. Alegro Health isn't out of it: Shoppers who want beginners wanting a low-cost 8-week compounded semaglutide starter with b12.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealVitara RXAlegro Health
Value Score91 (A)68 (C)
Est. first month$99/moFrom $199/mo (starting dose, compounded)
Save vs brand-name~93%~85%
Semaglutide$99/moFrom $199/mo (starting dose, compounded)
Tirzepatide$149/moNot disclosed
Both moleculesYesNo
PricingFlat — no step-upWatch
Coverage49 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

96
Lowest Real Price
72
Vitara RX: 96. Alegro Health: 72.
90
No Teaser-Rate Bait
64
Vitara RX: 90. Alegro Health: 64.
88
Nationwide Availability
45
Vitara RX: 88. Alegro Health: 45.
92
Both Molecules
62
Vitara RX: 92. Alegro Health: 62.
95
Easy Cancellation
95
Vitara RX: 95. Alegro Health: 95.
67
Reputation
60
Vitara RX: 67. Alegro Health: 60.

Vitara RX

VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.

Why it's a deal

  • Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
  • Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • Covers 49 states with an explicit state list, not vague "most states" language

The fine print

  • No corporate legal entity disclosed — only the trade name "VitaraRx"
  • No named medical director — all clinical decisions made by independent providers (marketplace model)
  • All sales final — no medication returns
  • Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
  • Doesn't ship to Alaska

Alegro Health

Alegro Health is a HIPAA telehealth practice based in McKinney, Texas that offers a low-cost compounded semaglutide weight-loss starter.

Why it's a deal

  • Low-cost entry point: 199 dollars for a full 8-week semaglutide starter with B12
  • Direct shipping with no recurring monthly fees
  • Operates from a physical Texas medical practice with a published phone number

The fine print

  • Semaglutide only; no tirzepatide offered
  • Available in select states only, which are not enumerated
  • Thin public information and compounding pharmacy not named on the site
Get the Vitara RX deal Get the Alegro Health deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to Alegro Health.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.